Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Senzime AB (SEZI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.8900 -0.1700    -2.81%
14:28:15 - Real-time Data. Currency in SEK ( Disclaimer )
  • Volume: 84,692
  • Bid/Ask: 5.8500 / 5.8800
  • Day's Range: 5.8000 - 6.0500
Type:  Equity
Market:  Sweden
ISIN:  SE0002478776 
S/N:  100566660
Senzime 5.8900 -0.1700 -2.81%

Senzime Company Profile

 
Read the Senzime AB company profile to learn more about the business and the management team. View Senzime AB facts about employee data, company products and services, and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.

Contact Information

Address Ulls vAeg 41
Uppsala, 756 51
Sweden
Phone 46 18 51 56 40
Fax -

Top Executives

Name Age Since Title
Per Wold Olsen - 2023 Chairman of the Board of Director
Eva Walde 60 2021 Independent Director
Patty Reilly - - Member of Clinical Advisory Board
Jennifer M. Hunter - - Member of Scientific Advisory Board
Lars I. Eriksson 66 - Member of Scientific Advisory Board
Cynthia A. Lien - 2022 Member of Scientific Advisory Board
Aaron F. Kopman - 2022 Member of Scientific Advisory Board
Adam Dahlberg 50 2000 Vice Chairman of the Board
Joseph D. Tobias - 2022 Member of Scientific Advisory Board
Ken B. Johnson - - Member of Clinical Advisory Board
Thomas Weber - - Member of Clinical Advisory Board
Alfredo Abad-Gurumeta - - Member of Scientific Advisory Board
Glenn S. Murphy - 2022 Member of Scientific Advisory Board
Bela Fulesdi - - Member of Scientific Advisory Board
Casper Claudius - - Member of Scientific Advisory Board
Sorin J. Brull 67 2016 Member of Clinical Advisory Board, Member of Scientific Advisory Board & Director
Hans D.de Boer - - Member of Scientific Advisory Board
Thomas Fuchs-Buder - - Member of Scientific Advisory Board
Malin Fagerlund - - Member of Clinical Advisory Board
Manfred Blobner - - Member of Scientific Advisory Board
Shane Angus - - Member of Clinical Advisory Board
Guy Cammu - - Member of Scientific Advisory Board
Jennifer Herzog-Niescery - - Member of Clinical Advisory Board
Claude Meistelman - - Member of Scientific Advisory Board
J. Ross Renew - 2022 Member of Scientific Advisory Board
Lars Axelson 62 2023 Director
Goran Brorsson 71 2023 Independent Director
Per Wold-Olsen 76 2023 Chairman of the Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SEZI Price Commentary

Write your thoughts about Senzime AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email